Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Development and Validation of the LC-MS/MS Method and Its Application for Pharmacokinetic Studies for the Simultaneous Estimation of Motixafortide and Filgrastim in rat Plasma.
Journal: Biomedical chromatography : BMC
Published: February 23, 2025
Small molecule and peptide CXCR4 antagonists. A patent review from 2019 to 2024.
Journal: Expert opinion on therapeutic patents
Published: February 10, 2025
Pharmacological aspects of FDA-approved novel drug therapies against cancer in 2023: a comprehensive review.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 05, 2025
FDA's stamp of approval: Unveiling peptide breakthroughs in cardiovascular diseases, ACE, HIV, CNS, and beyond.
Journal: Journal of peptide science : an official publication of the European Peptide Society
Published: April 26, 2024
A comparative review of Aphexda and Mozobil for mobilization prior to stem cell collection.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: April 17, 2024
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 20, 2024
CXCR4 as a therapeutic target in acute myeloid leukemia.
Journal: Leukemia
Published: January 11, 2024
Motixafortide Acetate.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: October 20, 2023
Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM).
Journal: Cell communication and signaling : CCS
Published: August 29, 2023
Last Updated: 10/31/2025